Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAITI: 166Ho-TARE Followed by Maintenance Therapy in Liver Limited Unresectable Colorectal Cancer
NCT06332079Phase 2Terminated
- Sponsor
- Gruppo Oncologico Nord Ovest
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in colorectal cancer (CRC), sponsored by Gruppo Oncologico Nord Ovest. Primary endpoint: Progression-free survival Rate at 36 months. Started Mar 2024; status: terminated.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06332079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06332079.